Starpharma Holdings Ltd (SPHRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 06-2024 | 12-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,470 | N/A | -5,355 | N/A | -10,528 |
| Depreciation Amortization | 693 | N/A | 731 | N/A | 803 |
| Other Working Capital | 817 | N/A | -918 | N/A | -701 |
| Other Operating Activity | 583 | -1,300 | 966 | 1,367 | 1,316 |
| Operating Cash Flow | $-4,377 | $-1,300 | $-4,576 | $1,367 | $-9,110 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -27 | -20 | -58 | -6 | -418 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 7 |
| Investing Cash Flow | $-27 | $-20 | $-58 | $-6 | $-411 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -730 | -684 | -3,113 | -3,351 | -468 |
| Financing Cash Flow | $-730 | $-684 | $-3,113 | $-3,351 | $-468 |
| Exchange Rate Effect | -16 | -4 | -5 | 3 | 67 |
| Beginning Cash Position | 15,128 | 15,219 | 23,071 | 22,923 | 33,605 |
| End Cash Position | 9,978 | 13,211 | 15,319 | 20,937 | 23,683 |
| Net Cash Flow | $-5,150 | $-2,009 | $-7,752 | $-1,987 | $-9,922 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,377 | -1,300 | -4,576 | 1,367 | -9,110 |
| Capital Expenditure | N/A | -20 | N/A | N/A | N/A |
| Free Cash Flow | -4,377 | -1,321 | -4,576 | 1,367 | -9,110 |